Trial Profile
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist Following Two Protocols of Ovulation Induction for Intrauterine Insemination
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Menotropin (Primary) ; LHRH receptor antagonists
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms PROMENIA
- Sponsors Ferring Pharmaceuticals
- 12 Apr 2011 New trial record